Jennison Associates LLC Clovis Oncology, Inc. Transaction History

Jennison Associates LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2018 Nov 08, 2018	SELL	$29.37 - $49.48 $20.3 Million - $34.2 Million	-690,563 Closed	0 $0
Q2 2018 Aug 02, 2018	SELL	$42.06 - $62.4 $294,966 - $437,611	-7,013 Reduced 1.01%	690,563 $31.4 Million
Q1 2018 Apr 20, 2018	BUY	$50.12 - $67.72 $4.71 Million - $6.36 Million	93,904 Added 15.56%	697,576 $36.8 Million
Q4 2017 Jan 25, 2018	BUY	$57.69 - $84.58 $202,088 - $296,283	3,503 Added 0.58%	603,672 $41.1 Million
Q3 2017 Nov 03, 2017	BUY	$67.17 - $84.81 $40.3 Million - $50.9 Million	600,169	600,169 $49.5 Million

166

Ticker CLVS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 144,480,000
Market Cap $13M
Description
Clovis Oncology, Inc., a biopharmaceutical company, focuses on acquiring, developing, and commercializing anti-cancer agents in the United States, Europe, and internationally. In the U.S., the company offers Rubraca (rucaparib), an oral small molecule inhibitor of poly ADP-ribose polymerase for recurrent epithelial ovarian, fallopian tube, or pr...

Get notified when there are updates to the investment portfolio of Jennison Associates LLC, based on Form 13F filings with the SEC.

Stay updated on Jennison Associates LLC with notifications on news.